Home /
Chemotherapy – Sir Charles Gairdner Hospital – Treatment Details
|
|
Description: |
Patients: This Phase II study involved 53 patients with malignant pleural mesothelioma; 45 men and 8 women. The median age was 63 years.
Treatment: The treatment consisted of two chemotherapy drugs; cisplatin (platinol) and gemcitabine (gemzar). Toxicity: Grade 3-4 toxicities included hematologic, diarrhea, infection, neurotoxicity, vomiting, and nausea. Results: Median survival was 11.2 months. Support: The study was supported in part by Eli Lilly. This company markets gemzar. Correspondence: M.J. Byrne, MD |